General
09:00 – 09:30 GMT, 16 November 2023 ‐ 30 mins
General
William Foster - Babraham Institute
09:30 – 10:00 GMT, 16 November 2023 ‐ 30 mins
William Foster - Babraham Institute
Techno Bite
10:00 – 10:15 GMT, 16 November 2023 ‐ 15 mins
Techno Bite
Yvan Saeys - VIB, Ghent
10:15 – 10:45 GMT, 16 November 2023 ‐ 30 mins
Yvan Saeys - VIB, Ghent
General
10:45 – 11:15 GMT, 16 November 2023 ‐ 30 mins
General
Raif Yuecel - University of Exeter
11:15 – 11:45 GMT, 16 November 2023 ‐ 30 mins
Raif Yuecel - University of Exeter
Techno Bite
11:45 – 12:00 GMT, 16 November 2023 ‐ 15 mins
Techno Bite
Christopher Hall - Wellcome Sanger Institute
12:00 – 12:30 GMT, 16 November 2023 ‐ 30 mins
Christopher Hall - Wellcome Sanger Institute
General
12:30 – 13:30 GMT, 16 November 2023 ‐ 1 hour
General
General
Bill Grey - University of York
13:40 – 14:10 GMT, 16 November 2023 ‐ 30 mins
Bill Grey - University of York
Techno Bite
14:10 – 14:25 GMT, 16 November 2023 ‐ 15 mins
Techno Bite
Raffaello Cimbro - AztraZeneca
14:25 – 14:55 GMT, 16 November 2023 ‐ 30 mins
Raffaello Cimbro - AztraZeneca
General
14:55 – 15:25 GMT, 16 November 2023 ‐ 30 mins
General
Melanie Jimenez - University of Strathclyde
15:25 – 15:55 GMT, 16 November 2023 ‐ 30 mins
Melanie Jimenez - University of Strathclyde
Techno Bite
15:55 – 16:10 GMT, 16 November 2023 ‐ 15 mins
Techno Bite
Prof J Paul Robinson - Purdue University
16:10 – 16:55 GMT, 16 November 2023 ‐ 45 mins
Prof J Paul Robinson - Purdue University
No bio provided
No bio provided
University of Exeter
No bio provided
Babraham Institute Flow cytometry Facility
Christopher has been working at the Babraham Institute since 2020 having previously been head of Flow Cytometry at EMBL in Rome and a Senior Research Assistant at the Cytometry Core Facility at the Sanger Institute in Cambridge, UK. Prior to working in flow cytometry Christopher was involved in the RAGULA clinical trial at King’s College London and worked as a microbiologist at GSK and Findus UK.
Christopher’s current flow cytometric obsession is full spectrum flow cytometry, from applying unmixing techniques to conventional machines, to applying spectral unmixing to novel biologic questions, to understanding the real world limitation of full spectrum where you may be better going back to conventional compensation.
In 2019 he was made an SRL Emerging Leader by the International Society for the Advancement of Cytometry.
University of York
No bio provided
AstraZeneca
No bio provided
No bio provided
No bio provided